Serial follow-up of repeat voluntary blood donors reactive for anti-HCV ELISA. - Wikidata - awgldk - TriplyDB

Serial follow-up of repeat voluntary blood donors reactive for anti-HCV ELISA.

Serial follow-up of repeat voluntary blood donors reactive for anti-HCV ELISA.

http://www.wikidata.org/entity/Q34862691

about

Need for nucleic Acid testing in countries with high prevalence of transfusion-transmitted infections.Screening for hepatitis C virus infection in a high prevalence country by an antigen/antibody combination assay versus a rapid test.Hepatitis C virus: Screening, diagnosis, and interpretation of laboratory assays.Repeat voluntary non-remunerated blood donor is the best quality indicator for blood safety.

P2860

Q36248372-9E40589B-8B8D-47AF-BFBC-BE8CE5E25339 Q37296858-B5B26101-D4C2-4DEC-973E-3F8EDD11DFDE Q37618606-422A4D55-E98A-4786-80C1-CEAD53660D60 Q42416749-7AC9550B-7CF6-4945-BF8D-2B34702ABCEA

P2860

Serial follow-up of repeat voluntary blood donors reactive for anti-HCV ELISA.

http://www.wikidata.org/entity/Q34862691

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Serial follow-up of repeat voluntary blood donors reactive for anti-HCV ELISA.

@ast

Serial follow-up of repeat voluntary blood donors reactive for anti-HCV ELISA.

@en

Serial follow-up of repeat voluntary blood donors reactive for anti-HCV ELISA.

@nl

type

label

Serial follow-up of repeat voluntary blood donors reactive for anti-HCV ELISA.

@ast

Serial follow-up of repeat voluntary blood donors reactive for anti-HCV ELISA.

@en

Serial follow-up of repeat voluntary blood donors reactive for anti-HCV ELISA.

@nl

prefLabel

Serial follow-up of repeat voluntary blood donors reactive for anti-HCV ELISA.

@ast

Serial follow-up of repeat voluntary blood donors reactive for anti-HCV ELISA.

@en

Serial follow-up of repeat voluntary blood donors reactive for anti-HCV ELISA.

@nl

P1433

Q34862691-28566642-08F7-4336-84A4-656038076197

P1476

Q34862691-6F0AF82A-862A-4838-9786-64644D4955D9

P2093

Q34862691-70722D51-0C17-418D-BD09-8541D37FDED9

Q34862691-84265BAD-4597-4D2E-AC14-FA6D22F4850D

Q34862691-8A8EA049-A2CB-46B5-BB53-E5CC5BEEC380

Q34862691-962A38D2-87D8-43AB-B3C9-66816D39D84E

Q34862691-D14ADA8F-E95A-41F8-BFE5-5F83320695D5

Q34862691-D826BC0F-302F-42E5-AF9F-DE1F02B91DFA

P2860

Q34862691-0233F9B9-6234-4F61-85D4-BCE3CDF09937

Q34862691-22C1E7ED-C248-4DC0-A71A-1F974C4F0DB5

Q34862691-3ADD1A15-E726-4364-9DA5-3546C3301539

Q34862691-42F82835-2A2E-404C-B4D0-E9DB80391646

Q34862691-4386EE9B-E6D1-4864-913A-909AF295FC57

Q34862691-AB5B8228-6860-44CA-8296-79353ACF6A93

Q34862691-BA3D45DA-D51C-42AF-A3F7-2C66EF017D4A

Q34862691-CE27CD98-0308-4BBA-BAC2-B6914D98335C

Q34862691-D0DF7568-DD76-4B08-A8C7-C9D0BC6D3032

Q34862691-D1EF4376-633B-480B-B754-1CEC542922C6

P304

Q34862691-47425D3E-FB27-42C3-B2BB-BA6F7E764C00

P31

Q34862691-418D4774-21EE-4991-9E13-B058EB476E1B

P356

Q34862691-11CBC53A-190A-463C-A7D7-260464B99661

P433

Q34862691-16E9D04B-014C-4E53-B8E3-3484CC5BBF37

P478

Q34862691-08B1BC8F-F17C-4498-AC34-14E0B0596B12

P577

Q34862691-33312594-941E-443B-B7BF-E1448254F744

P698

Q34862691-2F425592-CDB7-4E65-87DA-0630BAE6A6B8

P932

Q34862691-231F8C2A-3CCC-4C96-B1DE-DF3E804542B0

P356

0973-6247.75979

P1433

Asian Journal of Transfusion Science

P1476

Serial follow-up of repeat voluntary blood donors reactive for anti-HCV ELISA.

@en

P2093

Ankit Mathur

http://www.w3.org/2001/XMLSchema#string

N Choudhury

http://www.w3.org/2001/XMLSchema#string

Priti Desai

http://www.w3.org/2001/XMLSchema#string

Ripal Shah

http://www.w3.org/2001/XMLSchema#string

Sunita Tulsiani

http://www.w3.org/2001/XMLSchema#string

V Harimoorthy

http://www.w3.org/2001/XMLSchema#string

P2860

Factors associated with positive predictability of the anti-HCV ELISA method with confirmatory RT-PCR.

Transfusion medicine: looking to the future.

A rational use of laboratory tests in the diagnosis and management of hepatitis C virus infection.

Look-back of anti-HCV ELISA-positive, HCV-RNA PCR-negative donors and recipients of their blood products.

Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention.

Hepatitis C virus infection rate in volunteer blood donors from the Western Cape--comparison of screening tests and PCR.

A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors.

Risk factors for hepatitis C virus infection among blood donors in Beijing and implications for improving the pretesting donor screening process.

Donors whose blood reacts falsely positive in transfusion microbiology screening assays need not be lost to transfusion.

Improved efficiency of national HIV, HCV, and HTLV antibody testing algorithms based on sequential screening immunoassays.

P304

26-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0973-6247.75979

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21572711

http://www.w3.org/2001/XMLSchema#string

P932

3082711

http://www.w3.org/2001/XMLSchema#string